PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

245 hedge funds and large institutions have $4.83B invested in Pacific Biosciences in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 97 increasing their positions, 77 reducing their positions, and 39 closing their positions.

Holders
245
Holders Change
-16
Holders Change %
-6.13%
% of All Funds
4.3%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
25
Increased
97
Reduced
77
Closed
39
Calls
$31.8M
Puts
$47.5M
Net Calls
-$15.6M
Net Calls Change
-$21.3M

Top Buyers

1
William Blair Investment Management
1
William Blair Investment Management
Illinois
$105M
2
CC
2
Casdin Capital
New York
$204M
3
Capital International Investors
3
Capital International Investors
California
$291M
4
BBA
4
Baker Bros. Advisors
New York
$139M
5
AIM
5
ARK Investment Management
Florida
$581M

Top Sellers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$0
2
SM
2
SB Management
United Arab Emirates
$208M
3
ITP
3
Iron Triangle Partners
Connecticut
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$23.5M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$7M
Name Holding Trade Value Shares
Change 		Shares
Change %
ASN
276
Advisory Services Network
Georgia
– -$52K -1,500 Closed
Northwestern Mutual Wealth Management
277
Northwestern Mutual Wealth Management
Wisconsin
– -$19K -550 Closed
AWM
278
Accel Wealth Management
Iowa
– -$7K -195 Closed
PA
279
Perennial Advisors
New York
– -$3K -100 Closed
8 9 10 11
12